Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v7-EN
Language French English
Date Updated 2022-06-21 2022-06-15
Drug Identification Number 02395150 02395150
Brand name 0.9% SODIUM CHLORIDE INJECTION 0.9% SODIUM CHLORIDE INJECTION
Common or Proper name Sodium Chloride 0.9% Injection Sodium Chloride 0.9% Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 900MG 900MG
Dosage form(s) SOLUTION SOLUTION SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 100mL 100mL
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-05-04 2022-05-04
Actual start date 2022-05-04 2022-05-04
Estimated end date 2022-06-23 2022-06-23
Actual end date 2022-06-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to a shipment delay, we will be encountering a supply interruption on our Sodium Chloride 0.9% freeflex® Bag 100mL effective today, May 4, 2022 until May 23, 2022. Fresenius Kabi Canada regrets to advise that due to a shipment delay, we will be encountering a supply interruption on our Sodium Chloride 0.9% freeflex® Bag 100mL effective today, May 4, 2022 until May 23, 2022.
Health Canada comments